beta-amyloid (Abeta)42(43), abeta42, abeta40 and apoE immunostaining of plaques in fatal head injury. (Q53235445)

12 May 2018

title

beta-amyloid (Abeta)42(43), abeta42, abeta40 and apoE immunostaining of plaques in fatal head injury. (English)

1 reference

12 May 2018

author name string

Horsburgh K

1

1 reference

12 May 2018

Cole GM

2

1 reference

12 May 2018

Yang F

3

1 reference

12 May 2018

Savage MJ

4

1 reference

12 May 2018

Greenberg BD

5

1 reference

12 May 2018

Gentleman SM

6

1 reference

12 May 2018

Graham DI

7

1 reference

12 May 2018

Nicoll JA

8

1 reference

12 May 2018

publication date

1 April 2000

1 reference

12 May 2018

Neuropathology and Applied Neurobiology

published in

1 reference

12 May 2018

volume

26

1 reference

12 May 2018

issue

2

1 reference

12 May 2018

page(s)

124-132

1 reference

12 May 2018

Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2990.2000.026002124.X

A beta 42 is the predominant form of amyloid beta-protein in the brains of short-term survivors of head injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2990.2000.026002124.X

Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2990.2000.026002124.X

Amyloid beta-peptide is produced by cultured cells during normal metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2990.2000.026002124.X

Selective alterations in the cellular distribution of apolipoprotein E immunoreactivity following transient cerebral ischaemia in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2990.2000.026002124.X

Marked alterations in the cellular localisation and levels of apolipoprotein E following acute subdural haematoma in rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2990.2000.026002124.X

Abeta1-40 but not Abeta1-42 levels in cortex correlate with apolipoprotein E epsilon4 allele dosage in sporadic Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2990.2000.026002124.X

Visualization of A beta 42(43) and A beta 40 in senile plaques with end-specific A beta monoclonals: evidence that an initially deposited species is A beta 42(43).

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2990.2000.026002124.X

Regional differences in apolipoprotein E immunoreactivity in diffuse plaques in Alzheimer's disease brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2990.2000.026002124.X

Apolipoprotein E and the CNS response to injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2990.2000.026002124.X

Sequence of deposition of heterogeneous amyloid beta-peptides and APO E in Down syndrome: implications for initial events in amyloid plaque formation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2990.2000.026002124.X

Candidate gene for the chromosome 1 familial Alzheimer's disease locus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2990.2000.026002124.X

Preferential deposition of amyloid beta protein (Abeta) in the form Abeta40 in Alzheimer's disease is associated with a gene dosage effect of the apolipoprotein E E4 allele.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2990.2000.026002124.X

Synergistic effects of traumatic head injury and apolipoprotein-epsilon 4 in patients with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2990.2000.026002124.X

Apolipoprotein E genotype and deposits of Abeta40 and Abeta42 in Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2990.2000.026002124.X

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2990.2000.026002124.X

Apolipoprotein E ε4 allele is associated with deposition of amyloid β-protein following head injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2990.2000.026002124.X

Apolipoprotein E in animal models of CNS injury and in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2990.2000.026002124.X

Beta amyloid protein deposition in the brain after severe head injury: implications for the pathogenesis of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2990.2000.026002124.X

Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2990.2000.026002124.X

Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2990.2000.026002124.X

Apolipoprotein E distribution among different plaque types in Alzheimer's disease: implications for its role in plaque progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2990.2000.026002124.X

Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2990.2000.026002124.X

Production of the Alzheimer amyloid beta protein by normal proteolytic processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2990.2000.026002124.X

Amyloid precursor protein accumulates in regions of neurodegeneration following focal cerebral ischemia in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2990.2000.026002124.X

Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2990.2000.026002124.X

An increased percentage of long amyloid beta protein secreted by familial amyloid beta protein precursor (beta APP717) mutants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2990.2000.026002124.X

Association of apolipoprotein E polymorphism with outcome after head injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2990.2000.026002124.X

Carboxy terminal of beta-amyloid deposits in aged human, canine, and polar bear brains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2990.2000.026002124.X

Temporal profiles of accumulation of amyloid beta/A4 protein precursor in the gerbil after graded ischemic stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2990.2000.026002124.X

Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2990.2000.026002124.X

Seeding of A beta fibril formation is inhibited by all three isotypes of apolipoprotein E.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2990.2000.026002124.X

Amyloid-associated proteins α1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filaments

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2990.2000.026002124.X

10.1046/J.1365-2990.2000.026002124.X

21 January 2018

Identifiers

DOI

1 reference

12 May 2018

PubMed ID

10840275

1 reference

12 May 2018